(Q46972244)
Statements
A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone (English)
Minna Taskinen
Marja-Liisa Karjalainen-Lindsberg
Heidi Nyman
Leena-Maija Eerola
1 October 2007